A prospective observational pilot study to test the feasibility of a smartphone enabled uChek© urinalysis device to detect biomarkers in urine indicative of preeclampsia/eclampsia
This study sought to determine the feasibility of rural Bangladeshi midwives’ use of a novel urinalysis technology powered by an Android device and cuboid light box. The results of two to three antenatal care visits for 350 enrolled pregnant women demonstrate the potential of the mobile health devices in enhancing antenatal care in remote areas. The traditional urinalysis dipstick readings were comparable to the uChek© device readings across the three main parameters already covered by the traditional dipstick method. Our results further indicate that midwives were able to read and record additional parameters provided by the uChek© device including protein to creatinine ratios, and microalbuminuria, both of which are standardized biomarkers for preeclampsia that can be detected at 22 weeks gestation. In a qualitative evaluation conducted after the first antenatal care visits were completed, the midwives and their supervisors found the uChek© device easy to learn and easy to use. This study has implications for future mobile health projects which seek to introduce Android devices at the point of care and for the earlier detection of preeclampsia markers through urinalysis in low resource settings.
KeywordsPreeclampsia Eclampsia mHealth Bangladesh Antenatal care Mobile health
Allyson Cote, Emily Fallon, Nirdesh Tuladhar, Michael H Lee, MD, Vidya Sharma MBBS, MPH, Stephen D Simon PhD. Funding for the Study was from Merck for Mothers.
Compliance with ethical standards
Conflict of interest
There was no conflict of interest among any of the authors in this study. The uChek© units were purchased through a grant received by Maternova from Merck for Mothers for research purposes.
- 1.American Physiological Society. New biomarker predicts development of preeclampsia at six weeks of pregnancy. Science Daily; 2015. Available from: https://www.sciencedaily.com/releases/2015/11/151120104130.htm.
- 2.American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. American College of Obstetricians and Gynecologists; 2013. Available from: http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Hypertension-in-Pregnancy.
- 5.EngenderHealth. Balancing the Scales Expanding Treatment for Pregnant Women with Life-Threatening Hypertensive Conditions in Developing Countries. EngenderHealth; 2007. Available from: https://www.engenderhealth.org/files/pubs/maternal-health/engenderhealth-eclampsia-report.pdf.
- 6.Biosense Technologies Private Limited. uChek – technology. Biosense technologies; 2013. Available from: http://www.biosense.in/uchek.html.
- 7.Informa Pharma Intelligence. Technical specifications and accuracy of the uChek urine analyzer. Informa; 2013. Available from: https://www.pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Gray%20Sheet/39/20/uChek%20Technical%20specifications%20and%20Accuracy.pdf.
- 8.Eslamian L, Behnam F, Tehrani ZF, Jamal A, Maroosi V. Random urine protein creatinine ratio as a preadmission test in hypertensive pregnancies with urinary creatinine ratio. Acta Med Iran. 2011;49(2):81–4.Google Scholar
- 9.McNabb M, Chukwu E, Ojo O, Shekhar N, Gill C, Salami H, et al. Assessment of the quality of antenatal care services provided by health workers using a mobile phone decision support application in Northern Nigeria: a pre/post-intervention study. PLoS ONE. 10(5):e0123940. https://doi.org/10.1371/journal.pone.0123940.
- 10.Lund S, Nielsen BB, Hemed M, Boas IM, Said A, Said K et al. Mobile phones improve antenatal care attendance in Zanzibar: a cluster randomized controlled trial. BMC Pregnancy Childbirth. 2014; 14(29). doi: https://doi.org/10.1186/1471-2393-14-29.
- 11.Dalaba M, Akweongo P, Williams J, Saronga H, Tonchev P, Sauerborn R, et al. Costs associated with implementation of computer-assisted clinical decision support system for antenatal and delivery care: case study of Kassena-Nankana District of Northern Ghana. PLoS ONE. 9(9):e106416. https://doi.org/10.1371/journal.pone.0106416.
- 12.Sidaway P. Pre-eclampsia: Low-dose aspirin for pre-eclampsia. Nat Rev Nephrol. 2014;10(11):613.Google Scholar
- 13.World Health Organization (WHO). Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. World Health Organization; 2015. Available from: http://apps.who.int/iris/bitstream/10665/194254/1/9789241565141_eng.pdf?ua=1
- 14.National Institute of Population Research and Training. MEASURE Evaluation and icddr,b. Bangladesh maternal Mortality and Health Care Survey. MEASURE Evaluation; 2010. Available from: http://www.cpc.unc.edu/measure/resources/publications/tr-12-87.
- 17.Requejo J, Bryce J, Cesar V. Countdown to 2015: the 2014 report. UNICEF and WHO. 2014. Available from: http://www.countdown2015mnch.org/documents/2014Report/Countdown_to_2015-Fulfilling%20the%20Health_Agenda_for_Women_and_Children-The_2014_Report-Conference_Draft.pdf.
- 18.UNICEF. Resource mapping in Teknaf and Ukhia Upazillas of Cox's Bazar District. Institute of Water Modeling; 2009.Google Scholar
- 19.Ahmed S, Hill K. Maternal mortality estimation of at the subnational level: a model-based method with an application to Bangladesh. World Health Organization Bulletin; 2011, 89. Available from: http://www.who.int/bulletin/volumes/89/1/10-076851/en/, 12, 21.
- 20.World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. World Health Organization: 2012. Available from: http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548502/en/.